About Shenghua Pharmaceutical
Located in Guangzhou's International Bio-Island innovation hub, integrating advanced SPPS synthesis and high-resolution analytical QC instrumentation.
Scientific Clarity Over Marketing Rhetoric
The research peptide market is often saturated with ambiguous retail storefronts lacking verifiable chemistry credentials. Shenghua Pharmaceutical was established with a singular B2B objective: to function as a direct, technically accountable manufacturer offering authenticated analytical data with every shipment.
We maintain strict segregation between commercial inquiries and scientific evaluation. When you request a quotation or technical dossier, our bio-island synthesis specialists analyze sequence feasibility, solubility profiles, and appropriate lyophilization matrices to ensure your experimental protocols yield reliable data.
Full-Lifecycle Peptide Production
Our Guangzhou production operations encompass sequence modeling, automated SPPS assembly, multi-stage chromatographic separation, and sterile packaging.
Solid-Phase Synthesis (SPPS)
Automated microwave-assisted and continuous-flow peptide synthesizers engineered for long sequences (>30 amino acids) and complex modifications including cyclic disulfides and branched structures.
Preparative & Analytical HPLC
High-capacity DAC preparative columns isolate high-purity fractions, while analytical C18 chromatography stations evaluate final lot purity against stringent baseline standards.
Global Logistics Compliance
Every international shipment is packaged with temperature-protective insulation and complete customs clearance dossiers declaring laboratory research non-therapeutic status.
Ethical Positioning & Compliance Policy
Yunxi International Biotechnology (Guangzhou) Co., Ltd. does not manufacture, market, or distribute products for therapeutic, medical, diagnostic, dietary, or consumer use. All listed compounds are manufactured strictly as biological and chemical reference reagents for accredited laboratory investigations.